Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome by Mark N. Polizzotto, Thomas S. Uldrick, Duosha Hu, Robert Yarchoan

Get full text

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome by Mark N. Polizzotto, Thomas S. Uldrick, Duosha Hu, Robert Yarchoan

Get full text

Prevalence and incidence of hypertension in a heavily treatment-experienced cohort of people living with HIV in Uganda. by Dathan M Byonanebye, Mark N Polizzotto, Rosalind Parkes-Ratanshi, Joseph Musaazi, Kathy Petoumenos, Barbara Castelnuovo

Get full text

The Health Gym: synthetic health-related datasets for the development of reinforcement learning algorithms by Nicholas I-Hsien Kuo, Mark N. Polizzotto, Simon Finfer, Federico Garcia, Anders Sönnerborg, Maurizio Zazzi, Michael Böhm, Rolf Kaiser, Louisa Jorm, Sebastiano Barbieri

Get full text

Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome. by Nazzarena Labo, Wendell Miley, Vickie Marshall, William Gillette, Dominic Esposito, Matthew Bess, Alexandra Turano, Thomas Uldrick, Mark N Polizzotto, Kathleen M Wyvill, Rachel Bagni, Robert Yarchoan, Denise Whitby

Get full text

Evaluation of non-invasive multispectral imaging as a tool for measuring the effect of systemic therapy in Kaposi sarcoma. by Jana M Kainerstorfer, Mark N Polizzotto, Thomas S Uldrick, Rafa Rahman, Moinuddin Hassan, Laleh Najafizadeh, Yasaman Ardeshirpour, Kathleen M Wyvill, Karen Aleman, Paul D Smith, Robert Yarchoan, Amir H Gandjbakhche

Get full text

HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme by Nila J. Dharan, Tomas Radovich, Samuel Che, Kathy Petoumenos, Prabhjot Juneja, Matthew Law, Robin Huang, Hamish McManus, Mark N. Polizzotto, Rebecca Guy, Peter Cronin, David A. Cooper, Richard T. Gray

Get full text

Monoclonal antibody levels and protection from COVID-19 by Eva Stadler, Martin T. Burgess, Timothy E. Schlub, Shanchita R. Khan, Khai Li Chai, Zoe K. McQuilten, Erica M. Wood, Mark N. Polizzotto, Stephen J. Kent, Deborah Cromer, Miles P. Davenport, David S. Khoury

Get full text

Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia by Nila J. Dharan, Sarah C. Sasson, Golo Ahlenstiel, Christopher R. Andersen, Mark Bloch, Griselda Buckland, Nada Hamad, Win Min Han, Anthony D. Kelleher, Georgina V. Long, Gail V. Matthews, Michael M. Mina, Emmanuelle Papot, Kathy Petoumenos, Sanjay Swaminathan, Barbara Withers, James Yun, Mark N. Polizzotto

Get full text

Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia. by Nila J Dharan, Sarah C Sasson, Golo Ahlenstiel, Christopher R Andersen, Mark Bloch, Griselda Buckland, Nada Hamad, Win Min Han, Anthony D Kelleher, Georgina V Long, Gail V Matthews, Michael M Mina, Emmanuelle Papot, Kathy Petoumenos, Sanjay Swaminathan, Barbara Withers, James Yun, Mark N Polizzotto, CORIA Study Group

Get full text

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT by Emmanuelle Papot, Simone Jacoby, Dona Arlinda, Anchalee Avihingsanon, Iskandar Azwa, Margaret Borok, Dannae Brown, Mohamed Cissé, Sounkalo Dao, Nnakelu Eriobu, Richard Kaplan, Muhammad Karyana, Nagalingeswaran Kumarasamy, Johnnie Lee, Marcelo H. Losso, Gail V. Matthews, Leonardo Perelis, Carmen Perez-Casas, Kiat Ruxrungtham, Melynda Watkins, H. Clifford Lane, Anthony Kelleher, Matthew Law, Mark N. Polizzotto

Get full text